170. Low MHC Class I Expression in Pediatric Malignancies May Impede Success of MHC-Dependent Immunotherapies

Molecular Therapy - United States
doi 10.1016/s1525-0016(16)35183-8
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Elsevier BV


Related search